NCT03690336View on ClinicalTrials.gov

Adverse Event Data Collection From External Registries on Nonacog Beta Pegol

Enrolling by invitationOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

October 1, 2027

Study Completion Date

October 1, 2027

Conditions
Haemophilia B
Interventions
DRUG

Nonacog beta pegol

Treatment with commercially available nonacog beta pegol according to routine clinical practice at the discretion of the treating physician.

Trial Locations (2)

Unknown

PedNet Haemophilia Registry, Baarn

European Haemophilia Safety Surveillance Registry, Sheffield

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT03690336 - Adverse Event Data Collection From External Registries on Nonacog Beta Pegol | Biotech Hunter | Biotech Hunter